Wolfgang Schütte

1.9k total citations
44 papers, 599 citations indexed

About

Wolfgang Schütte is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Wolfgang Schütte has authored 44 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 8 papers in Immunology. Recurrent topics in Wolfgang Schütte's work include Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Wolfgang Schütte is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Wolfgang Schütte collaborates with scholars based in Germany, United States and Italy. Wolfgang Schütte's co-authors include Dagmar Riemann, Barbara Seliger, Joachim von Pawel, Kristiaan Nackaerts, Martin Steins, Paul Lorigan, Mary O’Brien, Leon Bosquée, Martin Reck and Robert M. Jotte and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Abnormal Psychology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Wolfgang Schütte

38 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Schütte Germany 10 372 230 221 160 97 44 599
H. Parmar United Kingdom 11 92 0.2× 107 0.5× 177 0.8× 88 0.6× 44 0.5× 18 521
Paul F. Rühle Germany 11 177 0.5× 39 0.2× 70 0.3× 69 0.4× 42 0.4× 12 458
Masayo Tsukamoto Japan 13 297 0.8× 86 0.4× 115 0.5× 150 0.9× 25 0.3× 36 612
Pranjali Dalvi United States 14 46 0.1× 134 0.6× 174 0.8× 250 1.6× 27 0.3× 21 539
G. Vandermoten Belgium 13 524 1.4× 162 0.7× 470 2.1× 210 1.3× 17 0.2× 21 753
Kajsa E. Affolter United States 11 233 0.6× 87 0.4× 94 0.4× 67 0.4× 14 0.1× 26 390
T. Phan United States 10 266 0.7× 163 0.7× 105 0.5× 182 1.1× 27 0.3× 18 530
Shengyang Qiu United Kingdom 11 223 0.6× 51 0.2× 88 0.4× 112 0.7× 29 0.3× 22 457
Reinhard Motz Austria 6 39 0.1× 99 0.4× 109 0.5× 45 0.3× 54 0.6× 9 365

Countries citing papers authored by Wolfgang Schütte

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Schütte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Schütte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Schütte more than expected).

Fields of papers citing papers by Wolfgang Schütte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Schütte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Schütte. The network helps show where Wolfgang Schütte may publish in the future.

Co-authorship network of co-authors of Wolfgang Schütte

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Schütte. A scholar is included among the top collaborators of Wolfgang Schütte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Schütte. Wolfgang Schütte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grohé, Christian, Jan Stratmann, Stefan Hammerschmidt, et al.. (2025). 1904P Real-world outcomes of nintedanib plus docetaxel for adenocarcinoma NSCLC after failure of first-line immunochemotherapy: The non-interventional VARGADO study. Annals of Oncology. 36. S1018–S1019.
2.
3.
Krüger, M., et al.. (2024). Solitary fibrous tumours of the pleura: do we need a different perspective on malignancy?. European Journal of Cardio-Thoracic Surgery. 65(4).
4.
Zhou, Caicun, Antonio Chella, M. Reck, et al.. (2024). OA01.04 IMpower010 5-y Subgroup Analysis and Relapse Patterns: Phase 3 Study of Atezolizumab vs BSC in Stage II-IIIA NSCLC. Journal of Thoracic Oncology. 19(10). S8–S9. 1 indexed citations
5.
6.
Evers, Georg, Daniel C. Christoph, Wolfgang M. Brueckl, et al.. (2023). 1300P Treatment and clinical outcome in recurrent/refractory locally advanced NSCLC following chemoradiotherapy and consolidative durvalumab. Annals of Oncology. 34. S749–S749.
7.
Milger, Katrin, Stephanie Korn, Jan Fuge, et al.. (2023). Kriterien zur Evaluation des Ansprechens auf Biologika bei schwerem Asthma – der Biologics Asthma Response Score (BARS). Pneumologie. 77(4). 220–232. 7 indexed citations
8.
Milger, Katrin, Stephanie Korn, Jan Fuge, et al.. (2023). Criteria for evaluation of response to biologics in severe asthma – the Biologics Asthma Response Score (BARS). Pneumologie. 79(6). 439–451. 8 indexed citations
9.
Krüger, M., et al.. (2021). Outcome of Repeat Pulmonary Metastasectomy. Advances in experimental medicine and biology. 1335. 37–44. 5 indexed citations
10.
11.
Griesinger, Frank, Wilfried Eberhardt, Petra Hoffknecht, et al.. (2020). 1364P Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C. Annals of Oncology. 31. S872–S872. 1 indexed citations
12.
Blankenburg, Thomas, et al.. (2017). Survival of Hypercapnic Patients with COPD and Obesity Hypoventilation Syndrome Treated with High Intensity Non Invasive Ventilation in the Daily Routine Care. The Open Respiratory Medicine Journal. 11(1). 31–40. 12 indexed citations
13.
14.
Schütte, Wolfgang. (2010). „Wirksame Behandlungschance nicht verschenken“. 13(1). 80–80.
15.
Manegold, Christian, Johan Vansteenkiste, Felipe Cardenal, et al.. (2009). A randomized, parallel-group, phase II study to evaluate the efficacy and safety of three doses of the integrin inhibitor cilengitide compared with docetaxel in patients with stage IV non-small cell lung cancer (NSCLC) after failure of first-line chemotherapy. Journal of Thoracic Oncology. 4(9). 1 indexed citations
16.
17.
Leschinger, Monika I., Karin Helsberg, Frank Langer, & Wolfgang Schütte. (2005). Gemcitabin in der First-line-Therapie des lokal fortgeschrittenen und metastasierten nicht-kleinzelligen Bronchialkarzinoms (NSCLC): Ergebnisübersicht randomisierter Phase-III-Studien. Oncology Research and Treatment. 28(1). 1–28. 6 indexed citations
18.
Blankenburg, Thomas, et al.. (2004). Survival of Patients in Clinical Stages I–IIIb of Non-Small-Cell Lung Cancer Treated with Radiation Therapy Alone. Strahlentherapie und Onkologie. 180(8). 488–496. 11 indexed citations
19.
Schütte, Wolfgang, C. Manegold, & Joachim von Pawel. (1998). Topotecan in the Therapy of Brain Metastases in Lung Cancer. Oncology Research and Treatment. 21(4). 25–27. 4 indexed citations
20.
Lücke, A., et al.. (1998). Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy. British Journal of Pharmacology. 124(2). 370–376. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Parmar Breakdown of academic impact, for papers by Paul F. Rühle Breakdown of academic impact, for papers by Masayo Tsukamoto Breakdown of academic impact, for papers by Pranjali Dalvi Breakdown of academic impact, for papers by G. Vandermoten Breakdown of academic impact, for papers by Kajsa E. Affolter Breakdown of academic impact, for papers by T. Phan Breakdown of academic impact, for papers by Shengyang Qiu Breakdown of academic impact, for papers by Reinhard Motz
Rankless by CCL
2026